Hexacyclonate

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Hexacyclonate
Hexacyclonate.svg
Systematic (IUPAC) name
[1-(hydroxymethyl)cyclohexyl]acetic acid
Clinical data
Legal status ?
Identifiers
CAS number 7491-42-1
ATC code ?
PubChem CID 23444
ChemSpider 21921 YesY
UNII 2K0FP9UB6A YesY
ChEMBL CHEMBL2110826
Chemical data
Formula C9H16O3 
Mol. mass 172.222
 YesY (what is this?)  (verify)

Hexacyclonate (Gevilon) is a stimulant drug. It was previously used for the treatment of alcoholism[1] and for increasing motivation in elderly patients,[2] but is now mainly used for the treatment of hyperlipoproteinaemia. [3][4]

The latter use may be incorrectly assigned, as "Gevilon" has been used as a trade name for gemfibrozil, a well-known drug for dislypidemia.




References[edit]

  1. ^ Chesrow EJ, Sabatini R, Musci JP, Kaplitze SE, Marquardt GH. Adjunctive treatment of the chronic alcoholic with hexacyclonate sodium. Illinois Medical Journal. 1962 May;121:546-8.
  2. ^ Morrison BO. Pharmaco-motivation of the geriatric patient: a preliminary report on hexacyclonate. Journal of the Louisiana State Medical Society. 1962 Jan;114:23-6.
  3. ^ Milewicz A, Plamieniak Z, Bohdanowicz-Pawlak A. Therapeutic effect of gevilon in patients with hyperlipoproteinaemia. Polish Journal of Medicine and Pharmacy. 1992 Apr-Jun;24(2):91-5.
  4. ^ Gazdikova K, Korecka P, Springer V, Gazdik F. Pharmacoeconomic aspects of patients treated by hemodialysis. Bratislavske Lekarske Listy. 2003;104(10):329-34.